SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000935836-14-000384
Filing Date
2014-06-30
Accepted
2014-06-30 13:55:36
Documents
1
Group Members
JON M. PLEXICOSTONEPINE CAPITAL MANAGEMENT, LLCTIMOTHY P. LYNCH

Document Format Files

Seq Description Document Type Size
1 stonepine13da.htm SC 13D/A 57681
  Complete submission text file 0000935836-14-000384.txt   59234
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79091 | Film No.: 14948316
SIC: 2834 Pharmaceutical Preparations

Mailing Address 475 GATE FIVE RD., SUITE 320 SAUSALITO CA 94965
Business Address 475 GATE FIVE RD., SUITE 320 SAUSALITO CA 94965 415.331.7100
STONEPINE CAPITAL L P (Filed by) CIK: 0001370042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A